6 results about "Sexual function" patented technology

The present invention relates to a pharmaceutical composition for improving sexual function, comprising a Salvia miltiorrhiza extract as an active ingredient. Specifically, the pharmaceutical composition can improve overall sexual satisfaction through the improvement of one or more selected from the group consisting of erectile function, sexual pleasure, sexual desire, and sexual intercourse satisfaction.

The application discloses a method for treating premature ejaculation by using high-frequency muscle-bone ultrasonic guiding razor needle to release the connective tissue of the dorsal nerve of penis, and belongs to the technical field of minimally invasive treatment of male sexual dysfunction. The method can accurately distinguish the course, branch and adjacent blood vessel level of the dorsal nerve of penis and mark the safe needle insertion area through real-time imaging of high-frequency muscle-bone ultrasound. A 0.4mm razor needle is used to perform longitudinal push-cut release in the interspace of the dorsal nerve of penis under the whole-process monitoring of ultrasound, so as to release the adhesion of the loose connective tissue under the skin and the high-tension structure. Then, transverse push-cut release is performed in the coronal sulcus area, so as to reduce the local sensory afferent excitability and prolong the ejaculation latency. The application realizes visual operation in the whole process, has small trauma and is controllable and accurate, does not damage the main stem of the nerve and the blood vessel, can stably improve the symptoms of premature ejaculation and is suitable for clinical standardization and popularization.

The invention relates to the technical field of probiotics, in particular to pediococcus acidilactici NH3 for treating male prostate and improving sexual function as well as a culture method and application of the pediococcus acidilactici NH3. The strain is preserved in Guangdong Microbial Culture Collection Center on April 18, 2025, and the preservation number is GDMCC No: 66163. The strain is a probiotic strain approved by the National Health Commission. The strain has the effects of regulating intestinal flora balance and promoting digestion and absorption of a human body, and also has the effects of treating male prostate and improving the sexual function. 5 billion strains and 50 milligrams of metabolites are given every day, so that the endophytic essential quantity of astragaloside, spinosin and psoralen can be continuously provided in the intestinal reproduction and growth process, the male prostate can be treated, the sexual function can be improved, and the body health can be kept.

The present invention relates to a complementary herbal composition for the treatment of oxalate kidney stones, urinary tract infections (UTIs), and sexual dysfunctions. The composition comprises a synergistic blend of herbal ingredients, including Rumex obstusifolius, Lessertia frutescens, Hypoxis hemerocallidea, Gunnera perpensa, Achillea millefolium, Echinacea purpurea, Taraxacum officinale, Epimedium sagittatum, and Rosa canina L., in specific quantities. The formulation is administered in a water base and preserved with Potassium sorbate. PHYTOCASD offers natural, multi-targeted therapeutic benefits, including dissolving oxalate kidney stones, preventing and treating UTIs, and improving sexual function. The invention is intended for use as a complementary medicine, leveraging the diuretic, antimicrobial, anti-inflammatory, and aphrodisiac properties of its ingredients to provide a comprehensive and safe treatment option for individuals suffering from these conditions.

The present invention relates to a pollen-based composition or an extract from a pollen-based composition, wherein the composition or extract stimulates the production of hyaluronic acid (HA). The composition or extract comprises at least glucose-6-phosphate as a substrate or precursor for hyaluronic acid (HA) production. The compositions or extracts of the present invention further comprise other small molecular weight bioactive molecules and / or compounds selected from the group comprising flavonoids, flavonols, flavones, alkaloids, aglycones, glycosides, lipids, fatty acids, amino acids, anthranilic acids and isomers thereof, spermidine and isomers thereof, a caffeoyl spermidine compound; and hydroxycinnamic acid. The invention also relates to formulations comprising a pollen-based composition or extract useful for the treatment of a variety of conditions, including skin problems and skin aging as well as symptoms of climacteric genitourinary syndrome (GSM), the symptoms of the climacteric genitourinary syndrome (GSM) include urinary incontinence, vaginal dryness, vaginal atrophy, irritation, pruritus, rhagadia, thinning, redness, inflammation and a decline in sexual desire, sexual function, sexual response and / or sexual pleasure.

The present invention relates to the use of a Herba Bovis extract in improving the ovarian reserve capacity of mice. The present invention also discloses a preparation method of the Herba Bovis extract. The Herba Bovis extract of the present invention has the effect of improving sexual function, and specifically can solve the problem of decreased ovarian reserve capacity due to repeated superovulation; the Herba Bovis extract can effectively alleviate follicular hypoplasia, prevent abnormal changes in serum hormones caused by repeated superovulation, and reduce the activation of primordial follicles, thereby slowing down the process of ovarian aging. Not only that, the Herba Bovis extract also effectively slows down cell apoptosis in the ovary and the polarization of macrophages to pro-inflammatory M1 macrophages, plays a protective role in the survival and maturation of oocytes, thereby protecting the reserve capacity of the ovary; the present invention develops a new function of Herba Bovis, and provides a new idea for the development of drugs to improve sexual function.